Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

[APACHE II and SAPS II as predictors of brain death development in neurocritical care patients].

Rocchetti NS, Egea-Guerrero JJ, Ruiz de Azua-Lopez Z, Martin-Villen L, Rodriguez-Rodriguez A, Vilches-Arenas A, Correa-Chamorro E, Settecase CJ, Bagilet DH.

Rev Neurol. 2018 Aug 16;67(4):121-128. Spanish.

PMID:
30039839
2.

Relation of RhoA in Peripheral Blood Mononuclear Cells With Severity of Aneurysmal Subarachnoid Hemorrhage and Vasospasm.

González-Montelongo MDC, Egea-Guerrero JJ, Murillo-Cabezas F, González-Montelongo R, Ruiz de Azúa-López Z, Rodríguez-Rodríguez A, Vilches-Arenas A, Castellano A, Ureña J.

Stroke. 2018 Jun;49(6):1507-1510. doi: 10.1161/STROKEAHA.117.020311. Epub 2018 May 7.

PMID:
29735721
3.

Short-term Results From a Training Program to Improve Organ Donation in Uncontrolled Donation After Circulatory Death.

Egea-Guerrero JJ, Martín-Villén L, Ruiz de Azúa-López Zaida Z, Bonilla-Quintero Francisco F, Pérez-López Enrique E, Marín-Andrés R, Correa-Chamorro E, Vilches-Arenas Á.

Transplant Proc. 2018 Mar;50(2):530-532. doi: 10.1016/j.transproceed.2017.09.074.

PMID:
29579843
4.

Usefulness of optic nerve ultrasound to predict clinical progression in multiple sclerosis.

Pérez Sánchez S, Eichau Madueño S, Rus Hidalgo M, Domínguez Mayoral AM, Vilches-Arenas A, Navarro Mascarell G, Izquierdo G.

Neurologia. 2018 Mar 21. pii: S0213-4853(18)30026-4. doi: 10.1016/j.nrl.2017.12.009. [Epub ahead of print] English, Spanish.

5.

Validation of S100B use in a cohort of Spanish patients with mild traumatic brain injury: a multicentre study.

Egea-Guerrero JJ, Rodríguez-Rodríguez A, Quintana-Díaz M, Freire-Aragón MD, Raya-Collados D, Hernández-García C, Ortiz-Manzano Á, Vilches-Arenas Á, Díez-Naz A, Guerrero JM, Murillo-Cabezas F.

Brain Inj. 2018;32(4):459-463. doi: 10.1080/02699052.2018.1429019. Epub 2018 Jan 22.

PMID:
29355397
6.

Rapid and simplified synthesis of [18F]Fluoromisonidazole and its use in PET imaging in an experimental model of subarachnoid hemorrhage.

Fernandez-Maza L, Egea-Guerrero JJ, Balcerzyk M, Civantos-Jubera G, Gordillo-Escobar E, Vilches-Arenas A, Fernandez-Gomez I, Parrado-Gallego A, Murillo-Cabezas F.

Appl Radiat Isot. 2018 Feb;132:79-84. doi: 10.1016/j.apradiso.2017.09.035. Epub 2017 Oct 3.

PMID:
29172058
7.

[Adenoma metanephric: Report of 2 cases and bibliographic review.]

Rodríguez-Zarco E, Vallejo-Benítez A, Farfán-López FJ, Vilches-Arenas Á, Pereira-Gallardo S, Vázquez-Ramírez FJ.

Arch Esp Urol. 2017 Nov;70(9):792-796. Review. Spanish.

PMID:
29099381
8.

The Effect of Monthly Medication on Mortality After a Coronary Event.

Montero-Balosa MC, Fernández-Urrusuno R, Vilches-Arenas A.

J Cardiovasc Pharmacol Ther. 2018 May;23(3):192-199. doi: 10.1177/1074248417732833. Epub 2017 Oct 4.

PMID:
28978235
9.

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results.

Argüelles-Arias F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, Castro Laria L, Maldonado Pérez B, Chaaro Benallal D, Benítez Roldán A, Merino V, Ramirez G, Calleja-Hernández MA, Caunedo Álvarez A, Romero Gómez M.

Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1290-1295. doi: 10.1097/MEG.0000000000000953.

10.

Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.

Argüelles-Arias F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, Castro Laria L, Maldonado Pérez B, Chaaro D, Benítez Roldán A, Merino V, Ramírez G, Caunedo Álvarez A, Romero Gómez M.

Dig Dis Sci. 2017 Aug;62(8):2203. doi: 10.1007/s10620-017-4657-0. No abstract available.

PMID:
28660487
11.

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response.

Cordero-Ruiz P, Carmona-Soria I, Rodríguez-Téllez M, Caunedo-Alvarez A, Quezada-Pacheco RH, Flores-Cucho A, Romero-Gómez M, Vilches-Arenas Á.

Eur J Gastroenterol Hepatol. 2017 Jul;29(7):792-799. doi: 10.1097/MEG.0000000000000886.

PMID:
28445251
12.

Prognostic value of total antioxidant capacity to predict functional outcome in traumatic brain injury patients.

Rodríguez-Rodríguez A, Egea-Guerrero JJ, Vilches-Arenas Á, Gordillo-Escobar E, Ruiz de Azúa-López Z, Murillo-Cabezas F.

Clin Chem Lab Med. 2017 Oct 26;55(11):e265-e267. doi: 10.1515/cclm-2017-0022. No abstract available.

PMID:
28412718
13.

Serum gelsolin levels in aneurismal subarachnoid hemorrhage: Preliminary results.

Rodríguez-Rodríguez A, Egea-Guerrero JJ, Ruiz de Azúa-López Z, Rivera-Rubiales G, Vilches-Arenas Á, Murillo-Cabezas F.

Med Intensiva. 2018 Jan - Feb;42(1):62-64. doi: 10.1016/j.medin.2017.01.010. Epub 2017 Mar 29. English, Spanish. No abstract available.

14.

Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.

Argüelles-Arias F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, Castro Laria L, Maldonado Pérez B, Chaaro D, Benítez Roldán A, Merino V, Ramírez G, Caunedo Álvarez A, Romero Gómez M.

Dig Dis Sci. 2017 May;62(5):1305-1312. doi: 10.1007/s10620-017-4511-4. Epub 2017 Mar 9. Erratum in: Dig Dis Sci. 2017 Jun 28;:.

15.

IMPACT Score for Traumatic Brain Injury: Validation of the Prognostic Tool in a Spanish Cohort.

Egea-Guerrero JJ, Rodríguez-Rodríguez A, Gordillo-Escobar E, Fernández-Delgado E, Martínez-Roldán Á, Roldán-Reina Á, Durán-Martínez P, de Vega-Ríos E, Freire-Aragón MD, Vilches-Arenas Á, Murillo-Cabezas F, Quintana-Díaz M.

J Head Trauma Rehabil. 2018 Jan/Feb;33(1):46-52. doi: 10.1097/HTR.0000000000000292.

PMID:
28195955
16.

Urotensinergic system genes in experimental subarachnoid hemorrhage.

Muñoz-Sánchez MÁ, Rodríguez-Rodríguez A, Egea-Guerrero JJ, Gordillo-Escobar E, Vilches-Arenas Á, Carrillo-Vico A, Guerrero JM, Murillo-Cabezas F.

Med Intensiva. 2017 Nov;41(8):468-474. doi: 10.1016/j.medin.2016.10.013. Epub 2017 Jan 9. English, Spanish.

17.

Comparison of two competitive enzyme immunoassay kits for quantification of plasma Urotensin-II in rats.

Rodríguez-Rodríguez A, Egea-Guerrero JJ, Vilches-Arenas Á, Quintanilla-Vázquez MJ, Murillo-Cabezas F, Muñoz-Sánchez MÁ.

J Immunoassay Immunochem. 2017;38(3):247-256. doi: 10.1080/15321819.2016.1250772. Epub 2016 Nov 1.

PMID:
27801612
18.

Multiple sclerosis and alcohol use disorders: In-hospital mortality, extended hospital stays, and overexpenditures.

Gili-Miner M, López-Méndez J, Vilches-Arenas A, Ramírez-Ramírez G, Franco-Fernández D, Sala-Turrens J, Béjar-Prado L.

Neurologia. 2016 Oct 22. pii: S0213-4853(16)30173-6. doi: 10.1016/j.nrl.2016.07.008. [Epub ahead of print] English, Spanish.

19.

The effectiveness and safety of pharmacological prophylaxis against venous thromboembolism in patients with moderate to severe traumatic brain injury: A systematic review and meta-analysis.

Mesa Galan LA, Egea-Guerrero JJ, Quintana Diaz M, Vilches-Arenas A.

J Trauma Acute Care Surg. 2016 Sep;81(3):567-74. doi: 10.1097/TA.0000000000001134. Review.

PMID:
27244574
20.

S100B and Neuron-Specific Enolase as mortality predictors in patients with severe traumatic brain injury.

Rodríguez-Rodríguez A, Egea-Guerrero JJ, Gordillo-Escobar E, Enamorado-Enamorado J, Hernández-García C, Ruiz de Azúa-López Z, Vilches-Arenas Á, Guerrero JM, Murillo-Cabezas F.

Neurol Res. 2016 Feb;38(2):130-7. doi: 10.1080/01616412.2016.1144410. Epub 2016 Mar 4.

PMID:
27078699

Supplemental Content

Loading ...
Support Center